Open-Label Study to Assess the Safety/Tolerability in Patients With Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Clinical Trials Related to Incyte Corporation
Related studies linked through entity extraction aliases.
A Dose Ranging Study of the Effect of Ruxolitinib Phosphate Cream When Applied to Participants With Plaque Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
Study to Determine the Safety and Efficacy of INCB018424 in Patients With Polycythemia Vera or Essential Thrombocythemia
- Status
- TERMINATED
- Phase
- PHASE2
Evaluate the Safety and Tolerability of INCB019602 When Administered With Metformin in Patients With Type 2 Diabetes
- Status
- TERMINATED
- Phase
- PHASE2
Safety and Efficacy of INCB013739 Plus Metformin Compared to Metformin Alone on Glycemic Control in Type 2 Diabetics
- Status
- COMPLETED
- Phase
- PHASE2
INCB018424 in Patients With Advanced Hematologic Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor (Ruxolitinib; INBC018424) in Patients With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ruxolitinib (INCB018424) Administered Orally to Patients With Androgen Independent Metastatic Prostate Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Open Label, Safety and Efficacy Study of Topical Investigational Drug to Treat Patients With Psoriasis
- Status
- COMPLETED
- Phase
- PHASE2
A Study Exploring the Safety, Tolerability and Efficacy of a 4 Week Course of INCB018424 in Subjects With Active Rheumatoid Arthritis
- Status
- COMPLETED
- Phase
- PHASE2
Open Label Ruxolitinib (INCB018424) in Patients With Myelofibrosis and Post Polycythemia Vera/Essential Thrombocythemia Myelofibrosis
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects
- Status
- COMPLETED
- Phase
- PHASE2
A Study of the Effect of INCB013739 on Cortisone Reducing Enzyme Activity in Obese People Predisposed to Diabetes
- Status
- COMPLETED
- Phase
- PHASE1
Safety/Effectiveness of Oral Chemokine Coreceptor 5 (CCR5) Antagonist INCB009471 in R5-tropic HIV Infected Patients
- Status
- COMPLETED
- Phase
- PHASE2
Randomized, Double-Blind Study Comparing Dexelvucitabine (DFC) to Lamivudine (3TC) in Subjects With Resistance to NRTIs, PIs, and NNRTIs
- Status
- TERMINATED
- Phase
- PHASE2